Analyst firms · Robert W. Baird · MEDP
Robert W. Baird MEDP price target and rating history
Medpace Holdings Inc. (MEDP) · Health Care
Robert W. Baird rates Medpace Holdings Inc. (MEDP) Neutral with a $547 price target, as of its latest action on Jul 8, 2026. It has published 4 rating actions on MEDP since October 2023, including 2 upgrades and 2 downgrades. Across 6 firms with a MEDP price target in the last 12 months, the median target is $518.50. Robert W. Baird's $547 is 5% above that.
- Current rating
- Neutral
- Price target
- $547
- Median target, all firms
- $518.50
- Actions on MEDP
- 4
Robert W. Baird price target on MEDP
Every Robert W. Baird rating on MEDP
- Jul 8, 2026
- Feb 10, 2026
- Oct 23, 2024
- Oct 24, 2023
How other firms rate MEDP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $673 | Sep 30, 2026 |
| Robert W. Baird | Neutral | $547 | Jul 8, 2026 |
| Jefferies | Hold | $515 | Jul 7, 2026 |
| Barclays | Equal Weight | $500 | Mar 6, 2026 |
| RBC Capital Markets | Outperform | $522 | Mar 3, 2026 |
| TD Cowen | Hold | $419 | Feb 18, 2026 |
Questions about Robert W. Baird and MEDP
- What is Robert W. Baird's price target for MEDP?
- Robert W. Baird's latest stated price target for Medpace Holdings Inc. (MEDP) is $547, from its action on Jul 8, 2026.
- What is Robert W. Baird's rating on MEDP?
- Robert W. Baird rates MEDP Neutral, a neutral rating, as of Jul 8, 2026.
- When did Robert W. Baird last change its view on MEDP?
- On Jul 8, 2026, Robert W. Baird downgrades to Neutral from Outperform, price target $547.
- How does Robert W. Baird's MEDP target compare with other analysts?
- Across 6 firms with a MEDP price target in the last 12 months, the median target is $518.50. Robert W. Baird's $547 is 5% above that.
More MEDP rating histories
All Robert W. Baird ratingsMEDP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.